Natera (NTRA) net income: −$208M
Natera reported a net loss of −$208M for the year ended Dec 31, 2025.
From Natera's filings with the SEC · Read the filing · NTRA stock page
Natera net income by year
#3,541 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | −$208M | – |
| Dec 31, 2024 | −$190M | – |
| Dec 31, 2023 | −$435M | – |
| Dec 31, 2022 | −$548M | – |
| Dec 31, 2021 | −$472M | – |
Net income of similar companies
Companies in the same industry as Natera, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| RadNet | −$18.6M | Dec 31, 2025 |
| CareDx | −$21.4M | Dec 31, 2025 |
| Caris Life Sciences | −$68.1M | Dec 31, 2025 |
| Celcuity | −$177M | Dec 31, 2025 |
| Natera | −$208M | Dec 31, 2025 |
| Guardant Health | −$416M | Dec 31, 2025 |
| Fortrea | −$989M | Dec 31, 2025 |
Questions and answers
What is Natera's net income?
Natera reported a net loss of −$208M for the year ended Dec 31, 2025.
Numbers as reported in Natera's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology